Literature DB >> 32770291

Multiple adenomatoid odontogenic tumours associated with eight impacted teeth.

Chané Nel1, André Uys2, Liam Robinson2, Willie F P van Heerden2.   

Abstract

Adenomatoid odontogenic tumour (AOT) is a benign tumour that arises from odontogenic epithelial remnants. AOTs usually present as innocuous lesions with limited growth potential. Multiple AOTs are frequently reported in the literature, with reports of tumours associated with up to seven impacted teeth. Multiple AOTs have also been described in association with Schimmelpenning syndrome. This case report highlights the rare occurrence of multiple AOTs involving eight impacted teeth in a 9-year-old male patient. Radiographic examination showed features of enamel hypoplasia and multiple prominent dilated gubernaculum dentis associated with some of the impacted teeth. The patient also presented with a linear epidermal nevus involving the left face and intraoral mucosal papillomatous growths, clinical features highly compatible with Schimmelpenning syndrome.

Entities:  

Keywords:  Adenomatoid odontogenic tumour; Gubernaculum dentis; Multiple impacted teeth; Schimmelpenning syndrome

Mesh:

Year:  2020        PMID: 32770291     DOI: 10.1007/s11282-020-00471-w

Source DB:  PubMed          Journal:  Oral Radiol        ISSN: 0911-6028            Impact factor:   1.852


  2 in total

1.  Adenomatoid odontogenic tumour of the mandible.

Authors:  Reinhard E Friedrich; Jozef Zustin; Hanna A Scheuer
Journal:  Anticancer Res       Date:  2010-05       Impact factor: 2.480

2.  Odontogenic adenomatoid tumor: report of case and review of the literature.

Authors:  P J Tsaknis; W M Carpenter; N L Shade
Journal:  J Oral Surg       Date:  1977-02
  2 in total
  1 in total

1.  Oral HRAS Mutation in Orofacial Nevus Sebaceous Syndrome (Schimmelpenning-Feuerstein-Mims-Syndrome): A Case Report With a Literature Survey.

Authors:  Reinhard E Friedrich; Martin Gosau; Andreas M Luebke; Christian Hagel; Felix K Kohlrusch; Michael Hahn; Simon VON Kroge; Jan Hahn; Ilse Wieland; Martin Zenker
Journal:  In Vivo       Date:  2022 Jan-Feb       Impact factor: 2.155

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.